Chadwick J, Berry C, Carpenter MA, Gulati G, Heck SL, Hinterberg MA, Holman RR, Lee MMY, Omland T, Paterson C, Petrie MC, Sattar N, Shah SH, Shrestha S, Sourij H, Troth EV, Vinje V, Williams SA (2025) Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects J Clin Pharmacol (in press) DOI 10.1002/jcph.70077, PubMed 40619592 Bønaa KH, Leiren OM, Våga BI, Vangberg G, Govatsmark RES, Kristensen A, Packer EJS, Wiseth R, Aaberge L, Halvorsen S, Mjølstad OC (2025) More STEMI patients should receive thrombolytic therapy Tidsskr Nor Laegeforen, 145 (8) DOI 10.4045/tidsskr.25.0202, PubMed 40575825 Atar D, Linde C (2025) Subclinical atrial fibrillation: Who benefits from oral anticoagulation? Kardiol Pol (in press) DOI 10.33963/v.phj.106733, PubMed 40512045
